主动脉瘤市场规模、份额和成长分析（按类型、治疗方法、产品、最终用途和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，全球主动脉瘤市场规模将达到 45.2 亿美元，到 2025 年将达到 49.6 亿美元，到 2033 年将达到 104.8 亿美元，预测期（2026-2033 年）的复合年增长率为 9.8%。

全球主动脉瘤市场受到人口老化和动脉粥状硬化盛行率上升的显着影响。有利的医疗报销政策推动了微创手术需求的激增。心血管疾病发生率上升、久坐不动的生活方式和不健康的饮食习惯等因素导致主动脉瘤发生率不断攀升。患者族群日益壮大，尤其是在已开发国家，这些国家65岁以上人口的比例很高。吸烟等风险因素进一步增加了动脉瘤发生的可能性。此外，微创技术（例如血管内动脉瘤修復术 (EVAR)）的兴起正在改变治疗方法，带来缩短恢復时间和改善患者预后等益处，从而推动市场成长。

全球主动脉瘤市场驱动因素

全球主动脉瘤市场需求成长主要受该疾病发生率上升的驱动，尤其是在老年人。高血压、吸烟和动脉粥状硬化等因素共同导致主动脉瘤盛行率上升，对先进的诊断和治疗方案产生了强烈的需求。为了有效应对这一严重的健康问题，医疗服务提供者正在积极寻求创新工具和治疗方法。这一趋势凸显了将主动脉瘤治疗作为医疗保健领域重点发展方向的重要性，从而推动了市场扩张以及对研发和技术的投资。

限制全球主动脉瘤市场的因素

全球主动脉瘤市场面临的一大挑战是公众和医疗服务提供者对该疾病的认知不足。这种知识鸿沟会导致漏诊和延误治疗，最终导致患者预后不佳。由于主动脉瘤的有效治疗依赖于及时诊断和治疗，这些因素会显着阻碍市场成长和发展。提高公众对疾病的认知和教育对于改善患者照护和推动市场发展至关重要。

全球主动脉瘤市场趋势

全球主动脉瘤市场正呈现出显着的发展趋势，包括人口老化和心血管疾病盛行率上升，这些因素推动了对先进诊断和治疗方案的需求。微创手术技术和血管内动脉瘤修復术（EVAR）的创新正在改善患者预后并缩短復原时间，进一步促进市场成长。此外，人工智慧（AI）和远端医疗在患者管理中的应用提高了诊断准确性并实现了个人化治疗。由于医疗专业人员和患者都优先考虑高效有效的解决方案，预计市场将持续扩张，这也凸显了该关键领域持续研发的必要性。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术进步
• 监管环境
• 专利分析

全球主动脉瘤市场规模（按类型划分）、复合年增长率（2026-2033 年）

• 胸主动脉瘤（TAA）
• 腹部主动脉血管瘤（AAA）

全球主动脉瘤市场规模（依治疗方法划分），复合年增长率（2026-2033 年）

• 开放性手术修復（OSR）
• 血管内动脉瘤修復术（EVAR）

全球主动脉瘤市场规模（依产品划分）、复合年增长率（2026-2033 年）

• 血管支架
• 导管
• 其他的

全球主动脉瘤市场规模（依最终用途划分）、复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心（ASC）
• 其他的

全球主动脉瘤市场规模：复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Medtronic（USA）
• WL Gore & Associates, Inc.（USA）
• Cook Medical（USA）
• Terumo Corporation（Japan）
• Cardinal Health（USA）
• Endologix, LLC（USA）
• Lombard Medical（UK）
• CryoLife, Inc.（USA）
• MicroPort Scientific Corporation（China）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Becton, Dickinson and Company（USA）
• Braun Melsungen AG（Germany）
• Getinge AB（Sweden）
• Merit Medical Systems, Inc.（USA）
• Terumo Aortic（UK）
• Biotronik SE & Co. KG（Germany）
• Medtronic Vascular, Inc.（USA）

结论与建议

Global Aortic Aneurysm Market size was valued at USD 4.52 Billion in 2024 and is poised to grow from USD 4.96 Billion in 2025 to USD 10.48 Billion by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The global aortic aneurysm market is significantly influenced by the growing elderly population and the rising prevalence of atherosclerosis. The demand for minimally invasive procedures is surging, supported by favorable health reimbursement policies. Factors such as an increase in cardiovascular diseases, sedentary lifestyles, and poor dietary habits contribute to the rising incidence of aortic aneurysms. With a considerable percentage of the population aged over 65, the patient demographic is expanding, particularly in developed nations. Risk factors like smoking further heighten the likelihood of aneurysm development. Additionally, the shift towards minimally invasive techniques, such as endovascular aneurysm repair (EVAR), is transforming treatment approaches, offering benefits like reduced recovery time and improved patient outcomes, thus fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Aneurysm Market Segments Analysis

Global Aortic Aneurysm Market is segmented by Type, Treatment, Product, End-Use and region. Based on Type, the market is segmented into Thoracic Aortic Aneurysm (TAA) and Abdominal Aortic Aneurysm (AAA). Based on Treatment, the market is segmented into Open Surgical Repair (OSR) and Endovascular Aneurysm Repair (EVAR). Based on Product, the market is segmented into Stent Grafts, Catheters and Others. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgery Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Aneurysm Market

The global market for aortic aneurysms is propelled by the growing occurrence of this condition, especially among older adults. Contributing elements like high blood pressure, tobacco use, and atherosclerosis are leading to a higher prevalence of aortic aneurysms, which in turn creates a strong demand for advanced diagnostic and therapeutic solutions. As the need for effective management of this serious health issue intensifies, healthcare providers are seeking innovative tools and treatments. This trend underscores the importance of addressing aortic aneurysms as a critical area for development within the medical field, driving market expansion and investment in research and technology.

Restraints in the Global Aortic Aneurysm Market

A major challenge facing the global aortic aneurysm market is the insufficient awareness regarding this condition among both the general public and healthcare providers. This knowledge gap can lead to a higher incidence of underdiagnosis and delayed medical intervention, ultimately contributing to adverse patient outcomes. Such factors can significantly impede the growth and development of the market, as effective management of aortic aneurysms is contingent upon timely diagnosis and treatment. Enhancing awareness and education around this condition is essential for improving patient care and driving the market forward.

Market Trends of the Global Aortic Aneurysm Market

The Global Aortic Aneurysm market is witnessing a notable trend characterized by an increasing demand for advanced diagnostic and therapeutic options driven by a growing aging population and the rising prevalence of cardiovascular diseases. Innovations in minimally invasive surgical techniques and endovascular aneurysm repair (EVAR) are enhancing patient outcomes while reducing recovery times, further propelling market growth. Additionally, the integration of artificial intelligence and telemedicine into patient management is improving diagnosis accuracy and treatment personalization. As healthcare professionals and patients alike prioritize efficient and effective solutions, the market is positioned for continued expansion, emphasizing the need for ongoing research and development in this critical area.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Aortic Aneurysm Market Size by Type & CAGR (2026-2033)

• Market Overview
• Thoracic Aortic Aneurysm (TAA)
• Abdominal Aortic Aneurysm (AAA)

Global Aortic Aneurysm Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Open Surgical Repair (OSR)
• Endovascular Aneurysm Repair (EVAR)

Global Aortic Aneurysm Market Size by Product & CAGR (2026-2033)

• Market Overview
• Stent Grafts
• Catheters
• Others

Global Aortic Aneurysm Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Others

Global Aortic Aneurysm Market Size & CAGR (2026-2033)

• North America (Type, Treatment, Product, End-Use)
  • US
  • Canada
• Europe (Type, Treatment, Product, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Product, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Product, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Product, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W.L. Gore & Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Aortic (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Vascular, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations